Literature DB >> 11724781

Defects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors.

Susan E Crawford1, Chao Qi, Parimal Misra, Veronica Stellmach, M Sambasiva Rao, James D Engel, Yijun Zhu, Janardan K Reddy.   

Abstract

Peroxisome proliferator activator receptor (PPAR)-binding protein (PBP) is an important coactivator for PPARgamma and other nuclear receptors. It has been identified as an integral component of a multiprotein thyroid hormone receptor-associated protein/vitamin D(3) receptor-interacting protein/activator-recruited cofactor complexes required for transcriptional activity. Here, we show that PBP is critical for the development of placenta and for the normal embryonic development of the heart, eye, vascular, and hematopoietic systems. The primary functional cause of embryonic lethality at embryonic day11.5 observed with PBP null mutation was cardiac failure because of noncompaction of the ventricular myocardium and resultant ventricular dilatation. There was a paucity of retinal pigment, defective lens formation, excessive systemic angiogenesis, a deficiency in the number of megakaryocytes, and an arrest in erythrocytic differentiation. Some of these defects involve PPARgamma and retinoid-sensitive sites, whereas others have not been recognized in the PPAR-signaling pathway. Phenotypic changes in four organ systems observed in PBP null mice overlapped with those in mice deficient in members of GATA, a family of transcription factors known to regulate differentiation of megakaryocytes, erythrocytes, and adipocytes. We demonstrate that PBP interacts with all five GATA factors analyzed, GATA-1, GATA-2, GATA-3, GATA-4, and GATA-6, and show that the binding of GATA-1, GATA-4, and GATA-6 to PBP is not dependent on the nuclear receptor recognition sequence motif LXXLL (where L is leucine and X is any amino acid) in PBP. Coexpression of PBP with GATA-3 markedly enhanced transcriptional activity of GATA-3 in nonhematopoietic cells. These observations identify the GATA family of transcription factors as a new interacting partner of PBP and demonstrate that PBP is essential for normal development of vital organ systems.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724781     DOI: 10.1074/jbc.M107995200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Peroxisome proliferators and peroxisome proliferator-activated receptor alpha: biotic and xenobiotic sensing.

Authors:  Janardan K Reddy
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

2.  Specific erythroid-lineage defect in mice conditionally deficient for Mediator subunit Med1.

Authors:  Melanie Stumpf; Xiaojing Yue; Sandra Schmitz; Hervé Luche; Janardan K Reddy; Tilman Borggrefe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-23       Impact factor: 11.205

Review 3.  Transcriptional mechanisms underlying hemoglobin synthesis.

Authors:  Koichi R Katsumura; Andrew W DeVilbiss; Nathaniel J Pope; Kirby D Johnson; Emery H Bresnick
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

4.  The Med1 subunit of the mediator complex induces liver cell proliferation and is phosphorylated by AMP kinase.

Authors:  Navin Viswakarma; Yuzhi Jia; Liang Bai; Qian Gao; Bingliang Lin; Xiaohong Zhang; Parimal Misra; Ajay Rana; Sanjay Jain; Frank J Gonzalez; Yi-Jun Zhu; Bayar Thimmapaya; Janardan K Reddy
Journal:  J Biol Chem       Date:  2013-08-13       Impact factor: 5.157

5.  MED1 phosphorylation promotes its association with mediator: implications for nuclear receptor signaling.

Authors:  Madesh Belakavadi; Pradeep K Pandey; Ravi Vijayvargia; Joseph D Fondell
Journal:  Mol Cell Biol       Date:  2008-04-07       Impact factor: 4.272

Review 6.  Med1 subunit of the mediator complex in nuclear receptor-regulated energy metabolism, liver regeneration, and hepatocarcinogenesis.

Authors:  Yuzhi Jia; Navin Viswakarma; Janardan K Reddy
Journal:  Gene Expr       Date:  2014

7.  ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity.

Authors:  Feng Jin; Shazia Irshad; Wei Yu; Madesh Belakavadi; Marina Chekmareva; Michael M Ittmann; Cory Abate-Shen; Joseph D Fondell
Journal:  Mol Cancer Res       Date:  2013-03-28       Impact factor: 5.852

Review 8.  PPARalpha: energy combustion, hypolipidemia, inflammation and cancer.

Authors:  Sean R Pyper; Navin Viswakarma; Songtao Yu; Janardan K Reddy
Journal:  Nucl Recept Signal       Date:  2010-04-16

9.  Coactivators in PPAR-Regulated Gene Expression.

Authors:  Navin Viswakarma; Yuzhi Jia; Liang Bai; Aurore Vluggens; Jayme Borensztajn; Jianming Xu; Janardan K Reddy
Journal:  PPAR Res       Date:  2010-08-05       Impact factor: 4.964

10.  Differential coregulator requirements for function of the hematopoietic transcription factor GATA-1 at endogenous loci.

Authors:  Nathaniel J Pope; Emery H Bresnick
Journal:  Nucleic Acids Res       Date:  2010-01-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.